nodes	percent_of_prediction	percent_of_DWPC	metapath
Eletriptan—ABCB1—adrenal gland cancer	0.875	1	CbGaD
Eletriptan—HTR7—sympathetic nervous system—adrenal gland cancer	0.00904	0.219	CbGeAlD
Eletriptan—HTR7—vein—adrenal gland cancer	0.00846	0.205	CbGeAlD
Eletriptan—CYP2C19—urine—adrenal gland cancer	0.00484	0.117	CbGeAlD
Eletriptan—CYP2C9—urine—adrenal gland cancer	0.00375	0.0907	CbGeAlD
Eletriptan—CYP3A4—urine—adrenal gland cancer	0.00286	0.0691	CbGeAlD
Eletriptan—CYP2D6—urine—adrenal gland cancer	0.00281	0.068	CbGeAlD
Eletriptan—HTR2B—adrenal cortex—adrenal gland cancer	0.00153	0.037	CbGeAlD
Eletriptan—HTR2B—adrenal gland—adrenal gland cancer	0.00111	0.0267	CbGeAlD
Eletriptan—HTR7—gonad—adrenal gland cancer	0.00109	0.0263	CbGeAlD
Eletriptan—HTR1A—adrenal gland—adrenal gland cancer	0.000991	0.024	CbGeAlD
Eletriptan—HTR7—adrenal gland—adrenal gland cancer	0.000947	0.0229	CbGeAlD
Eletriptan—PTGS1—cardiac atrium—adrenal gland cancer	0.00075	0.0181	CbGeAlD
Eletriptan—PTGS1—pituitary gland—adrenal gland cancer	0.000733	0.0177	CbGeAlD
Eletriptan—PTGS1—adrenal gland—adrenal gland cancer	0.000655	0.0158	CbGeAlD
Eletriptan—ABCB1—adrenal cortex—adrenal gland cancer	0.000536	0.013	CbGeAlD
Eletriptan—ABCB1—gonad—adrenal gland cancer	0.000444	0.0107	CbGeAlD
Eletriptan—ABCB1—pituitary gland—adrenal gland cancer	0.000433	0.0105	CbGeAlD
Eletriptan—ABCB1—adrenal gland—adrenal gland cancer	0.000387	0.00936	CbGeAlD
Eletriptan—HTR1E—Signaling by GPCR—GNAS—adrenal gland cancer	0.000119	0.00143	CbGpPWpGaD
Eletriptan—HTR1A—GPCR ligand binding—GNAS—adrenal gland cancer	0.000117	0.0014	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000116	0.00139	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—GNRHR—adrenal gland cancer	0.000114	0.00137	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000114	0.00136	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000114	0.00136	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—MEN1—adrenal gland cancer	0.000114	0.00136	CbGpPWpGaD
Eletriptan—HTR7—GPCR ligand binding—POMC—adrenal gland cancer	0.000106	0.00128	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000106	0.00127	CbGpPWpGaD
Eletriptan—HTR1D—GPCR ligand binding—POMC—adrenal gland cancer	0.000106	0.00127	CbGpPWpGaD
Eletriptan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000105	0.00126	CbGpPWpGaD
Eletriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000104	0.00124	CbGpPWpGaD
Eletriptan—HTR1B—GPCR ligand binding—POMC—adrenal gland cancer	0.000104	0.00124	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—TSHR—adrenal gland cancer	0.000103	0.00124	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—PRKACA—adrenal gland cancer	0.0001	0.0012	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—ZNRF3—adrenal gland cancer	0.0001	0.0012	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—PRKACA—adrenal gland cancer	9.95e-05	0.00119	CbGpPWpGaD
Eletriptan—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	9.75e-05	0.00117	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—PRKACA—adrenal gland cancer	9.74e-05	0.00117	CbGpPWpGaD
Eletriptan—HTR2B—GPCR ligand binding—POMC—adrenal gland cancer	9.73e-05	0.00117	CbGpPWpGaD
Eletriptan—HTR7—Circadian rythm related genes—TP53—adrenal gland cancer	9.46e-05	0.00113	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—CDC42—adrenal gland cancer	9.35e-05	0.00112	CbGpPWpGaD
Eletriptan—HTR1F—GPCR downstream signaling—POMC—adrenal gland cancer	9.35e-05	0.00112	CbGpPWpGaD
Eletriptan—CYP2C19—Biological oxidations—POMC—adrenal gland cancer	9.31e-05	0.00112	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—RRM1—adrenal gland cancer	9.31e-05	0.00112	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—SDHD—adrenal gland cancer	9.31e-05	0.00112	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—CDC42—adrenal gland cancer	9.29e-05	0.00111	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—GNRH1—adrenal gland cancer	9.25e-05	0.00111	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—PRKACA—adrenal gland cancer	9.19e-05	0.0011	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—GNRH1—adrenal gland cancer	9.18e-05	0.0011	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—PRKACA—adrenal gland cancer	9.15e-05	0.0011	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—CDC42—adrenal gland cancer	9.1e-05	0.00109	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	9.07e-05	0.00109	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—GNRH1—adrenal gland cancer	8.99e-05	0.00108	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	8.98e-05	0.00108	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—GNAS—adrenal gland cancer	8.94e-05	0.00107	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—GNAS—adrenal gland cancer	8.88e-05	0.00106	CbGpPWpGaD
Eletriptan—HTR1E—GPCR downstream signaling—POMC—adrenal gland cancer	8.82e-05	0.00106	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—SDHD—adrenal gland cancer	8.8e-05	0.00106	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—RRM1—adrenal gland cancer	8.8e-05	0.00106	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—GNAS—adrenal gland cancer	8.69e-05	0.00104	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—PRKACA—adrenal gland cancer	8.67e-05	0.00104	CbGpPWpGaD
Eletriptan—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	8.57e-05	0.00103	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—CDC42—adrenal gland cancer	8.55e-05	0.00102	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—CDC42—adrenal gland cancer	8.49e-05	0.00102	CbGpPWpGaD
Eletriptan—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	8.49e-05	0.00102	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—POMC—adrenal gland cancer	8.49e-05	0.00102	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—SPRY2—adrenal gland cancer	8.46e-05	0.00101	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—GNRH1—adrenal gland cancer	8.45e-05	0.00101	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—CDC42—adrenal gland cancer	8.44e-05	0.00101	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—SPRY2—adrenal gland cancer	8.4e-05	0.00101	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—SDHB—adrenal gland cancer	8.33e-05	0.000998	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—CDC42—adrenal gland cancer	8.26e-05	0.00099	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—TSHR—adrenal gland cancer	8.24e-05	0.000988	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—SPRY2—adrenal gland cancer	8.23e-05	0.000986	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	8.19e-05	0.000982	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—TSHR—adrenal gland cancer	8.19e-05	0.000981	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—GNAS—adrenal gland cancer	8.17e-05	0.000979	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—SDHB—adrenal gland cancer	8.13e-05	0.000974	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—GNAS—adrenal gland cancer	8.11e-05	0.000973	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—GNAS—adrenal gland cancer	8.06e-05	0.000966	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—TSHR—adrenal gland cancer	8.02e-05	0.000961	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—POMC—adrenal gland cancer	8.01e-05	0.00096	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—GNAS—adrenal gland cancer	7.89e-05	0.000946	CbGpPWpGaD
Eletriptan—HTR1A—GPCR ligand binding—POMC—adrenal gland cancer	7.89e-05	0.000946	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—CDC42—adrenal gland cancer	7.79e-05	0.000934	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—CDC42—adrenal gland cancer	7.76e-05	0.00093	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—MEN1—adrenal gland cancer	7.75e-05	0.000929	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—SPRY2—adrenal gland cancer	7.73e-05	0.000926	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—MEN1—adrenal gland cancer	7.7e-05	0.000923	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—SDHB—adrenal gland cancer	7.66e-05	0.000918	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—SDHB—adrenal gland cancer	7.59e-05	0.00091	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—MEN1—adrenal gland cancer	7.54e-05	0.000904	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—TSHR—adrenal gland cancer	7.53e-05	0.000903	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—IGF2—adrenal gland cancer	7.51e-05	0.000901	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—GNAS—adrenal gland cancer	7.45e-05	0.000893	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—PRKACA—adrenal gland cancer	7.42e-05	0.000889	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—GNAS—adrenal gland cancer	7.41e-05	0.000889	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—CDC42—adrenal gland cancer	7.35e-05	0.000881	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—IGF1R—adrenal gland cancer	7.26e-05	0.000871	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—IGF2—adrenal gland cancer	7.09e-05	0.00085	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—MEN1—adrenal gland cancer	7.08e-05	0.000849	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—GNAS—adrenal gland cancer	7.02e-05	0.000842	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—MED12—adrenal gland cancer	6.94e-05	0.000832	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—CDC42—adrenal gland cancer	6.93e-05	0.000831	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—IGF1R—adrenal gland cancer	6.85e-05	0.000821	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—GNRH1—adrenal gland cancer	6.85e-05	0.000821	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	6.67e-05	0.000799	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—GNAS—adrenal gland cancer	6.62e-05	0.000794	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—MED12—adrenal gland cancer	6.56e-05	0.000787	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	6.55e-05	0.000786	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—CDC42—adrenal gland cancer	6.29e-05	0.000754	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—SPRY2—adrenal gland cancer	6.27e-05	0.000751	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—TERT—adrenal gland cancer	6.25e-05	0.00075	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	6.2e-05	0.000744	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TSHR—adrenal gland cancer	6.11e-05	0.000732	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	6.08e-05	0.000729	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—POMC—adrenal gland cancer	6.02e-05	0.000721	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—GNAS—adrenal gland cancer	6.01e-05	0.000721	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—POMC—adrenal gland cancer	5.98e-05	0.000717	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	5.98e-05	0.000716	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	5.97e-05	0.000715	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—PRKACA—adrenal gland cancer	5.91e-05	0.000709	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—TERT—adrenal gland cancer	5.9e-05	0.000707	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—PRKACA—adrenal gland cancer	5.88e-05	0.000704	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—POMC—adrenal gland cancer	5.85e-05	0.000702	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—PRKACA—adrenal gland cancer	5.75e-05	0.00069	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—MEN1—adrenal gland cancer	5.74e-05	0.000688	CbGpPWpGaD
Eletriptan—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	5.6e-05	0.000671	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—POMC—adrenal gland cancer	5.5e-05	0.000659	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—POMC—adrenal gland cancer	5.46e-05	0.000655	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—BAD—adrenal gland cancer	5.44e-05	0.000652	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—POMC—adrenal gland cancer	5.43e-05	0.000651	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—PRKACA—adrenal gland cancer	5.4e-05	0.000648	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—SDHD—adrenal gland cancer	5.37e-05	0.000643	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—RRM1—adrenal gland cancer	5.37e-05	0.000643	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—POMC—adrenal gland cancer	5.31e-05	0.000637	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—SDHD—adrenal gland cancer	5.24e-05	0.000628	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—RRM1—adrenal gland cancer	5.24e-05	0.000628	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—BAD—adrenal gland cancer	5.13e-05	0.000615	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PRKACA—adrenal gland cancer	5.06e-05	0.000607	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CDC42—adrenal gland cancer	5.02e-05	0.000601	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—POMC—adrenal gland cancer	5.01e-05	0.000601	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—SDHB—adrenal gland cancer	5.01e-05	0.0006	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—POMC—adrenal gland cancer	4.99e-05	0.000599	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CDC42—adrenal gland cancer	4.98e-05	0.000597	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—BRAF—adrenal gland cancer	4.95e-05	0.000594	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	4.95e-05	0.000593	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—SDHD—adrenal gland cancer	4.94e-05	0.000592	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—RRM1—adrenal gland cancer	4.94e-05	0.000592	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	4.93e-05	0.000591	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—RRM1—adrenal gland cancer	4.89e-05	0.000587	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—SDHD—adrenal gland cancer	4.89e-05	0.000587	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CDC42—adrenal gland cancer	4.88e-05	0.000585	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—IGF2—adrenal gland cancer	4.84e-05	0.00058	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—IGF2—adrenal gland cancer	4.8e-05	0.000576	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—EGFR—adrenal gland cancer	4.8e-05	0.000575	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—GNAS—adrenal gland cancer	4.79e-05	0.000575	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PRKACA—adrenal gland cancer	4.79e-05	0.000574	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—GNAS—adrenal gland cancer	4.76e-05	0.000571	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—POMC—adrenal gland cancer	4.73e-05	0.000567	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	4.73e-05	0.000567	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—IGF2—adrenal gland cancer	4.7e-05	0.000564	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—IGF1R—adrenal gland cancer	4.67e-05	0.00056	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—BRAF—adrenal gland cancer	4.67e-05	0.00056	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—GNAS—adrenal gland cancer	4.66e-05	0.000559	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—IGF1R—adrenal gland cancer	4.64e-05	0.000557	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CDC42—adrenal gland cancer	4.58e-05	0.00055	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—IGF1R—adrenal gland cancer	4.55e-05	0.000545	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—EGFR—adrenal gland cancer	4.53e-05	0.000543	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—POMC—adrenal gland cancer	4.46e-05	0.000534	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—IGF2—adrenal gland cancer	4.42e-05	0.00053	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PRKACA—adrenal gland cancer	4.38e-05	0.000525	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—GNAS—adrenal gland cancer	4.38e-05	0.000525	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—IGF1R—adrenal gland cancer	4.27e-05	0.000512	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—GNAS—adrenal gland cancer	4.1e-05	0.000492	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—POMC—adrenal gland cancer	4.05e-05	0.000485	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—ABCB1—adrenal gland cancer	4.03e-05	0.000483	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—TERT—adrenal gland cancer	4.02e-05	0.000482	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—MED12—adrenal gland cancer	4e-05	0.00048	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—TERT—adrenal gland cancer	4e-05	0.000479	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	3.97e-05	0.000476	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—TERT—adrenal gland cancer	3.91e-05	0.000469	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—MED12—adrenal gland cancer	3.9e-05	0.000468	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—GNAS—adrenal gland cancer	3.88e-05	0.000465	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—ABCB1—adrenal gland cancer	3.81e-05	0.000456	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CDC42—adrenal gland cancer	3.72e-05	0.000446	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—MED12—adrenal gland cancer	3.68e-05	0.000441	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—TERT—adrenal gland cancer	3.68e-05	0.000441	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—MED12—adrenal gland cancer	3.65e-05	0.000437	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IGF2—adrenal gland cancer	3.58e-05	0.00043	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—CTNNB1—adrenal gland cancer	3.58e-05	0.000429	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	3.58e-05	0.000429	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—GNAS—adrenal gland cancer	3.55e-05	0.000426	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—BAD—adrenal gland cancer	3.5e-05	0.00042	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—BAD—adrenal gland cancer	3.48e-05	0.000417	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IGF1R—adrenal gland cancer	3.46e-05	0.000415	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—BAD—adrenal gland cancer	3.41e-05	0.000408	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—CTNNB1—adrenal gland cancer	3.38e-05	0.000405	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	3.26e-05	0.000391	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—POMC—adrenal gland cancer	3.23e-05	0.000387	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—RRM1—adrenal gland cancer	3.23e-05	0.000387	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—SDHD—adrenal gland cancer	3.23e-05	0.000387	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—POMC—adrenal gland cancer	3.21e-05	0.000384	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—BAD—adrenal gland cancer	3.2e-05	0.000384	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—BRAF—adrenal gland cancer	3.19e-05	0.000382	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—BRAF—adrenal gland cancer	3.17e-05	0.00038	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—POMC—adrenal gland cancer	3.14e-05	0.000376	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—BRAF—adrenal gland cancer	3.1e-05	0.000372	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—EGFR—adrenal gland cancer	3.09e-05	0.00037	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—EGFR—adrenal gland cancer	3.07e-05	0.000368	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—EGFR—adrenal gland cancer	3e-05	0.00036	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TERT—adrenal gland cancer	2.98e-05	0.000358	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—POMC—adrenal gland cancer	2.95e-05	0.000354	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	2.92e-05	0.00035	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—BRAF—adrenal gland cancer	2.91e-05	0.000349	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.85e-05	0.000342	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PRKACA—adrenal gland cancer	2.85e-05	0.000341	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—EGFR—adrenal gland cancer	2.83e-05	0.00034	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—EGFR—adrenal gland cancer	2.82e-05	0.000338	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—POMC—adrenal gland cancer	2.76e-05	0.000331	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	2.68e-05	0.000322	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—EGFR—adrenal gland cancer	2.67e-05	0.000321	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	2.66e-05	0.000319	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—POMC—adrenal gland cancer	2.61e-05	0.000313	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.6e-05	0.000312	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—BAD—adrenal gland cancer	2.59e-05	0.000311	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—MED12—adrenal gland cancer	2.41e-05	0.000288	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—POMC—adrenal gland cancer	2.39e-05	0.000287	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—TP53—adrenal gland cancer	2.38e-05	0.000285	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—GNAS—adrenal gland cancer	2.37e-05	0.000284	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—BRAF—adrenal gland cancer	2.36e-05	0.000283	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	2.32e-05	0.000278	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—GNAS—adrenal gland cancer	2.31e-05	0.000277	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CTNNB1—adrenal gland cancer	2.3e-05	0.000276	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—EGFR—adrenal gland cancer	2.29e-05	0.000274	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CTNNB1—adrenal gland cancer	2.29e-05	0.000274	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—TP53—adrenal gland cancer	2.25e-05	0.000269	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CTNNB1—adrenal gland cancer	2.24e-05	0.000269	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PTGS2—adrenal gland cancer	2.2e-05	0.000264	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GNAS—adrenal gland cancer	2.18e-05	0.000261	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GNAS—adrenal gland cancer	2.16e-05	0.000259	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	2.13e-05	0.000256	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	2.12e-05	0.000254	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CTNNB1—adrenal gland cancer	2.1e-05	0.000252	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PTGS2—adrenal gland cancer	2.08e-05	0.00025	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—EGFR—adrenal gland cancer	1.82e-05	0.000219	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—EGFR—adrenal gland cancer	1.81e-05	0.000217	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—EGFR—adrenal gland cancer	1.78e-05	0.000213	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	1.76e-05	0.00021	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CTNNB1—adrenal gland cancer	1.71e-05	0.000205	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—EGFR—adrenal gland cancer	1.67e-05	0.0002	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—POMC—adrenal gland cancer	1.59e-05	0.000191	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—POMC—adrenal gland cancer	1.55e-05	0.000186	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—TP53—adrenal gland cancer	1.53e-05	0.000184	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—TP53—adrenal gland cancer	1.52e-05	0.000182	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—TP53—adrenal gland cancer	1.49e-05	0.000179	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—POMC—adrenal gland cancer	1.46e-05	0.000176	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—POMC—adrenal gland cancer	1.45e-05	0.000174	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GNAS—adrenal gland cancer	1.42e-05	0.000171	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—TP53—adrenal gland cancer	1.4e-05	0.000168	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	1.4e-05	0.000167	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—EGFR—adrenal gland cancer	1.35e-05	0.000162	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	1.27e-05	0.000152	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PTGS2—adrenal gland cancer	1.24e-05	0.000149	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	1.17e-05	0.00014	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	1.16e-05	0.000139	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TP53—adrenal gland cancer	1.14e-05	0.000136	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—POMC—adrenal gland cancer	9.58e-06	0.000115	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	7.64e-06	9.16e-05	CbGpPWpGaD
